WEDNESDAY, May 3, 2023 (HealthDay News) — Another experimental drug meant for Alzheimer’s disease looks so promising that drugmaker Eli Lilly plans to ask the U.S. Food and Drug Administration for full approval by the end of June. Known as donanemab, the medication clears amyloid plaque from the brain. InContinue Reading

FRIDAY, April 21, 2023 (HealthDay News) – Taking a particular sleep medication may help stave off Alzheimer’s disease, but it’s too soon to say for sure after a preliminary study. Researchers at Washington University School of Medicine in St. Louis found that participants who took a sleeping pill called suvorexantContinue Reading

FRIDAY, April 14, 2023 (HealthDay News) — Cutting-edge AI technologies that can detect subtle changes in a person’s voice may help doctors diagnose Alzheimer’s disease and other cognitive impairments even before other symptoms begin. In a new study, researchers used advanced machine learning and natural language processing (NLP) tools toContinue Reading

WEDNESDAY, April 5, 2023 (HealthDay News) — A new national Alzheimer’s disease and dementia database could be a game changer for research on the memory-robbing condition that now affects more than 6 million Americans. Planning has begun at the National Institute on Aging (NIA) to fund the data platform. AContinue Reading

FRIDAY, March 17, 2023 (HealthDay News) — It’s well-established that American football players can suffer significant brain impacts as they age. Now, new research shows that elite European soccer players are also more likely than the average person to develop dementia. Men in the Swedish top soccer division between 1924Continue Reading